Axios @axios
NIAID said early this morning that it is "concerned" that AstraZeneca "may have included outdated information" from a trial of its COVID-19 vaccine that "may have provided an incomplete view of the efficacy data." https://t.co/15FvKbinTR — PolitiTweet.org